Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
2.51M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
380K
-
Shares change
-
+379K
-
Total reported value, excl. options
-
$540K
-
Value change
-
+$538K
-
Number of buys
-
8
-
Number of sells
-
-1
-
Price
-
$1.42
Significant Holders of REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB) as of Q3 2025
10 filings reported holding REVB - REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share as of Q3 2025.
REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 380K shares
of 2.51M outstanding shares and own 15.14% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (207K shares), ARMISTICE CAPITAL, LLC (80K shares), DRW Securities, LLC (77.3K shares), JANE STREET GROUP, LLC (14.8K shares), Tower Research Capital LLC (TRC) (534 shares), SBI Securities Co., Ltd. (458 shares), BANK OF AMERICA CORP /DE/ (14 shares), UBS Group AG (2 shares), DANSKE BANK A/S (1 shares), and CITIGROUP INC (1 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.